Transgenic mice designed to constitutively express Stat3 under the control of ARR2Pb develop PIN but fail to progress to malignant adenocarcinoma; however, when crossed with PTEN+/−  mutant mice, the resultant double knockouts develop invasive adenocarcinomas [56]. The gene discussed is PTEN; the disease is adenocarcinoma.